aP2 inhibiting compounds are provided having the formula
##STR1##
wherein R1, R2, R3, R4, X-Z and
##STR2##
are as described herein.
A method is also provided for treating diabetes and related diseases, especially
Type II diabetes, employing such aP2 inhibitor or a combination of such aP2 inhibitor
and another antidiabetic agent such as metformin, glyburide, troglitazone and/or insulin.